Patent Number definition

Patent Number means a reference number identifying a patent.
Sample 1Sample 2Sample 3
Patent Number. Sub Sta Abandon Date Grant Date BP6322 U.S.A. 10 Sep 1986 905543 ABN 01 Jan 1989 BP6322A PHILIPPINES 10 Sep 1987 35798 XXX XX0000X XXXXXX 08 Sep 1987 546354 XXX XX0000X XXXXXXXXX 10 Sep 1987 87/078224 607935 ISS 01 Aug 1991 BP6322A ISRAEL 09 Sep 1987 83842 83842 ISS 02 Oct 1991 BP6322A MALAYSIA 10 Sep 1987 XX0000000 MY101368A ISS 05 Sep 1991 BP6322A DENMARK 09 Sep 1987 87/004700 169071 ISS 08 Aug 1994 BP6322A IRELAND 09 Sep 1987 87/002406 60423 ISS 08 Jul 1994 BP6322A KOREA SOUTH 10 Sep 1987 87/010028 107765 ISS 15 Nov 1996 BP6322A HUNGARY 09 Sep 1987 87/004018 198016 ISS 19 Apr 1989 BP6322A PORTUGAL 09 Sep 1987 85668 85668 XXX 00 Xxx 0000 XX0000X XXXXX 09 Sep 1987 87/224204 2110963 ISS 21 Nov 1996 BP6322A EUR PATENT 05 Sep 1987 87113010.0 0260555 ISS 22 Apr 1992 BP6322A BELGIUM 05 Sep 1987 UNKN 0260555 ISS 22 Apr 1992 BP6322A FRANCE 05 Sep 1987 UNKN 0260555 ISS 22 Apr 1992 BP6322A GREAT BRITAIN 05 Sep 1987 UNKN 0260555 ISS 22 Apr 1992 BP6322A ITALY 05 Sep 1987 UNKN 0260555 ISS 22 Apr 1992 BP6322A LUXEMBOURG 05 Sep 1987 UNKN 0260555 ISS 22 Apr 1992 BP6322A NETHERLANDS 05 Sep 1987 UNKN 0260555 ISS 22 Apr 1992 BP6322A SPAIN 05 Sep 1987 UNKN 0260555 ISS 22 Apr 1992 BP6322A SWEDEN 05 Sep 1987 UNKN 0260555 ISS 22 Apr 1992 BP6322A SWITZERLAND 05 Sep 1987 UNKN 0260555 ISS 22 Apr 1992 BP6322A GREECE 05 Sep 1987 UNKN 3004962 ISS 22 Apr 1992 BP6322A GERMANY 05 Sep 1987 P3778463.3-08 3778463 ISS 22 Apr 1992 BP6322A AUSTRIA 05 Sep 1987 UNKN E0075223 ISS 22 Apr 1992 Docket Number Country Name Appl. Date Applic. Number Patent Number Sub Sta Abandon Date Grant Date BP6322A RUSSIAN FED 09 Sep 1987 4203411/04 1582984 ISS 23 Dec 1988 BP6322A U.S.A. 16 Jul 1987 07/071028 4876269 ISS 24 Oct 1989 BP6322A FINLAND 09 Sep 1987 87/003896 88298 ISS 26 Apr 1993 BP6322A MEXICO 10 Sep 1987 008173 170515 ISS 27 Aug 1993 BP6322A NEW ZEALAND 08 Sep 1987 221726 221726 ISS 28 Aug 1990 BP6322A NORWAY 09 Sep 1987 87/003762 172934 ISS 29 Sep 1993 XX0000X XXXXX XXXXXX 10 Sep 1987 87/006778 87/006778 ISS 30 May 1989 BP6322A TAIWAN 09 Sep 1987 76105341 031661 ISS 31 Jul 1989 DuPont Legal Patent Division License Agreement: NorthStar & Endo Pharmaceuticals DuP 769 Exhibit A 27 October 1997
Sample 1
Patent Number. Sub Sta Abandon Date Grant Date BP6295 U.S.A. 02 Dec 1985 803222 4722928 ABN 02 Aug 1995 02 Feb 1988 BP6295 JAPAN 01 Dec 1986 86/284459 1966196 ISS 25 Aug 1995 BP6295 1 JAPAN 24 May 1993 93/121382 2017591 ISS 19 Feb 1996 BP6295A U.S.A. 01 Oct 1987 07/103213 ABN 01 Aug 1989 BP6295B U.S.A. 27 Jul 1989 07/391406 4990617 ISS 05 Feb 1991
Sample 1

Examples of Patent Number in a sentence

  • Patent Number if Applicable Country Application Number Patent Expiration Date Owner prior to Acquisition and Merger Owner after Acquisition and Merger License Agreement (if applicable) [***] [***] [***] [***] [***] [***] [***] [***] Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission.

  • Application Number Filing Date Patent Number Grant Date Official Title 01-12.

  • The nitrogen sealed glass containers preserve the freshness of the flower and essential terpenes to improve the “entourage effect.” The USPTO issued Grown Rogue United States Patent Number 10,358,282 on July 23, 2019.

  • Country Patent Number or Serial Number Issued Filed Expiration [Confidential Information Omitted and filed separately with the Securities and Exchange Commission].

  • Schedules to Asset Purchase and Sale Agreement Schedule 1.1(a) - Purchased IP Docket Number Title Country Status Application Number Patent Number [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] CERTAIN CONFIDENTIAL PORTIONS OF THIS EXHIBIT WERE OMITTED AND REPLACED WITH “[***]”.

  • EXHIBIT C Licensed RCT Patent Right Country Status Application Number Application Date Patent Number Grant Date [...

  • Exhibit A to Recordable Assignment of Patents Docket Number Title Country Status Application Number Patent Number [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] CERTAIN CONFIDENTIAL PORTIONS OF THIS EXHIBIT WERE OMITTED AND REPLACED WITH “[***]”.

  • Exhibit A to Recordable Assignment of Patents Docket Number Title Country Status Application Number Patent Number [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] [***] CERTAIN CONFIDENTIAL PORTIONS OF THIS EXHIBIT WERE OMITTED AND REPLACED WITH “[***]”.

  • In connection with its formation, CAT issued 144,770,504 shares of its $0.00001 par value common stock to MedCom in exchange for MedCom assigning to CAT U.S. Patent Number 6,032,859 (the “Patent”) as MedCom’s capital contribution in and for consideration of the 144,770,504 shares.

  • The Shipowner is the sole owner of the whole of the Panamanian flag vessel, “[ ● ]” with Permanent Patent Number [ ● ], which is duly documented in the name of the Shipowner under the laws and flag of the Republic of Panama, which vessel is further described on Schedule I attached hereto and made a part hereof.


More Definitions of Patent Number

Patent Number. 2154609 Title: HCMV Monocolonal Antibodies and their use in infection of HCMV injection and HCMV Specific IGM, methods of detect ING viral antigens Country: United Kingdom Next Renewal Due: 18 February 1998
Sample 1
Patent Number. 2019131 Date Granted and Issued: October 29, 1996 XXXXXX XXXXXX XXXISTRATION: Patent Number: 5,086,402 Date Granted and Issued: February 4, 1992 48 6 (ii) Other than the trade-mark Xxxositions and Section 45 actions to which Simware Inc. is a party (as disclosed in the following tables), there are no other proceedings or actions before any court, tribunal (including the United States Patent and Trademark Office ("PTO") or equivalent authority anywhere in the world) related to any Company Intellectual Property. PROCEEDINGS INITIATED BY THE CORPORATION I. OPPOSITIONS BY SIMWARE INC. CANADA (ACTIVE) TRADE-MARK & SERIAL NO. STATUS OF TAB APPLICANT & FILING DATE OPPOSITION --- ---------------- ------------- ---------- 65. OSIM & Design 855,156 Rule 42 evidence due Originalsim Inc. September 4, 1997 Applicants deadline: October 19, 1999 66. ORIGINALSIM 847,228 Rule 42 evidence due Originalsim Inc. June 6, 1997 Applicants deadline: October 19, 1999 67. SIMEX 848,389 Rule 41 evidence due ANDREAS RU(beta) June 18, 1997 Opponent's deadline: November 28, 1999
Sample 1
Patent Number. [*] PCT Patent Number: [*]
Sample 1
Patent Number. [*] Issued: [*] PCT Patent Number: [*] [*] Certain information on this page has been omitted and filed separately with the Commission. Confidential treatment has been requested with respect to the omitted portions.
Sample 1

Related to Patent Number

  • Patent means (a) all patents and patent applications in any country or supranational jurisdiction in the Territory, (b) any substitutions, divisionals, continuations, continuations-in-part, provisional applications, reissues, renewals, registrations, confirmations, re-examinations, extensions, supplementary protection certificates and the like of any such patents or patent applications, and (c) foreign counterparts of any of the foregoing.

  • Patent Rights means the rights and interests in and to issued patents and pending patent applications (which, for purposes of this Agreement, include certificates of invention, applications for certificates of invention and priority rights) in any country or region, including all provisional applications, substitutions, continuations, continuations-in-part, divisions, renewals, all letters patent granted thereon, and all reissues, re-examinations and extensions thereof, and all foreign counterparts of any of the foregoing.

  • Client Application means an application developed by Customer that a) utilizes the Runtime Product, b) is installed fully on an end user’s machine, with all report processing local to that machine, and c) adds significant and primary functionality to the Runtime Product.